GALM

UniProt ID: Q96C23
Organism: Homo sapiens
Review Status: IN PROGRESS
πŸ“ Provide Detailed Feedback

Gene Description

GALM is the cytosolic aldose 1-epimerase (galactose mutarotase; EC 5.1.3.3) that catalyzes the first step of the Leloir pathway of galactose metabolism. It interconverts the beta- and alpha-anomers of D-galactose (beta-D-galactose <=> alpha-D-galactose), maintaining the anomeric equilibrium and ensuring a sufficient supply of the alpha-anomer, which galactokinase (GALK1) requires as its substrate; the downstream Leloir enzymes GALK1, GALT, and GALE then convert galactose into glucose 1-phosphate. GALM also mutarotates D-glucose (alpha-D-glucose <=> beta-D-glucose), though it prefers galactose over glucose. The enzyme is a monomer with a single-domain beta-sandwich fold typical of the aldose epimerase family; catalysis uses His-176 as the proton donor and Glu-307 as the proton acceptor, with His-107 also contributing. Biallelic loss-of-function GALM variants cause galactose mutarotase deficiency (galactosemia type IV, GALAC4), an autosomal recessive inborn error of galactose metabolism.

Existing Annotations Review

GO Term Evidence Action Reason
GO:0033499 beta-D-galactose catabolic process via UDP-galactose, Leloir pathway
IBA
GO_REF:0000033
ACCEPT
Summary: Phylogenetic (IBA) inference that GALM participates in the Leloir pathway of galactose catabolism. This is the core biological process of GALM: it catalyzes the first (mutarotase) step supplying alpha-D-galactose to GALK1.
Reason: Consistent with the experimentally established Leloir-pathway role and the PANTHER aldose-1-epimerase family. Represents a core function.
GO:0004034 aldose 1-epimerase activity
IBA
GO_REF:0000033
ACCEPT
Summary: Phylogenetic (IBA) inference of aldose 1-epimerase activity, the core molecular function of GALM, matching the family-level assignment for PTN000009552.
Reason: The defining catalytic activity of GALM, independently supported by direct experimental characterization (PMID:12753898). Core molecular function.
GO:0006006 glucose metabolic process
IBA
GO_REF:0000033
KEEP AS NON CORE
Summary: Phylogenetic inference that GALM participates in glucose metabolism, reflecting the family's ability to mutarotate glucose in addition to galactose.
Reason: GALM does mutarotate D-glucose in vitro, but with lower affinity/turnover than galactose (KM 54 mM vs 37 mM; kcat 4900 vs 12000 s-1), and the enzyme "exhibits a preference for galactose over glucose" (PMID:12753898). Glucose mutarotation is a genuine but secondary activity, not the core physiological role.
Supporting Evidence:
PMID:12753898
the protein has aldose 1-epimerase activity and exhibits a preference for galactose over glucose
GO:0004034 aldose 1-epimerase activity
IEA
GO_REF:0000120
ACCEPT
Summary: Automated (RHEA/EC 5.1.3.3) assignment of aldose 1-epimerase activity, the core molecular function.
Reason: Correctly mapped from EC 5.1.3.3 / RHEA:10264,RHEA:28675 to the specific MF term; matches experimental evidence.
GO:0005737 cytoplasm
IEA
GO_REF:0000044
ACCEPT
Summary: Subcellular-location mapping (UniProt SL-0086) placing GALM in the cytoplasm.
Reason: Consistent with the UniProt subcellular location (Cytoplasm) and the Reactome cytosol annotation. Broader than cytosol but not incorrect.
GO:0005975 carbohydrate metabolic process
IEA
GO_REF:0000002
KEEP AS NON CORE
Summary: InterPro2GO mapping to the high-level carbohydrate metabolic process, from the aldose epimerase domains.
Reason: True but a very general grouping term. The specific galactose/hexose processes below are more informative; retained as a non-core parent.
GO:0016853 isomerase activity
IEA
GO_REF:0000002
MODIFY
Summary: InterPro2GO mapping to the generic parent term isomerase activity.
Reason: Correct but overly general: GALM's activity is specifically aldose 1-epimerase activity (GO:0004034), which is a descendant of isomerase activity and is already annotated with strong experimental support. Replace the generic parent with the specific MF.
Proposed replacements: aldose 1-epimerase activity
GO:0019318 hexose metabolic process
IEA
GO_REF:0000120
KEEP AS NON CORE
Summary: Automated mapping (UniPathway/InterPro) to hexose metabolic process, consistent with GALM acting on the hexoses galactose and glucose.
Reason: Accurate parent term encompassing galactose and glucose metabolism, but less specific than the galactose process terms. Retained as a non-core grouping term.
GO:0030246 carbohydrate binding
IEA
GO_REF:0000002
MARK AS OVER ANNOTATED
Summary: InterPro2GO mapping to carbohydrate binding, derived from the sugar-binding beta-sandwich (GH-type carbohydrate-binding) domain signatures.
Reason: GALM binds galactose/glucose only transiently as catalytic substrates in its active site, not as a lectin-type carbohydrate-binding module. GO:0030246 (carbohydrate binding) implies a dedicated binding function distinct from catalysis; this is an over-annotation propagated from the structural fold signature. The catalytic substrate interaction is already captured by the aldose 1-epimerase activity annotation.
GO:0033499 beta-D-galactose catabolic process via UDP-galactose, Leloir pathway
TAS
Reactome:R-HSA-70370
ACCEPT
Summary: Reactome-curated (TAS) assignment of GALM to the Leloir pathway of galactose catabolism.
Reason: Curator-asserted pathway membership matching the established biology; core biological process.
GO:0006012 galactose metabolic process
IEA
GO_REF:0000041
ACCEPT
Summary: UniPathway-based (UPA00214) mapping to galactose metabolic process.
Reason: Core biological process of GALM; the anomer interconversion it catalyzes initiates galactose metabolism. Independently supported by IDA (PMID:12753898).
GO:0004034 aldose 1-epimerase activity
EXP
PMID:12753898
Identification and characterisation of human aldose 1-epimer...
ACCEPT
Summary: Experimental demonstration that recombinant human GALM has aldose 1-epimerase activity, with confirmed catalytic residues.
Reason: Core molecular function, directly demonstrated by enzyme assays on purified recombinant protein plus site-directed mutagenesis of catalytic residues.
Supporting Evidence:
PMID:12753898
Enzyme assays show that the protein has aldose 1-epimerase activity and exhibits a preference for galactose over glucose. Site-directed mutagenesis confirmed the involvement of three residues involved in catalysis and substrate binding.
GO:0004034 aldose 1-epimerase activity
TAS
Reactome:R-HSA-9931926
ACCEPT
Summary: Reactome-curated (TAS) assertion of aldose 1-epimerase activity (in the context of the defective-GALM reaction).
Reason: Core molecular function; consistent with all other MF evidence.
GO:0005829 cytosol
TAS
Reactome:R-HSA-9931853
ACCEPT
Summary: Reactome-curated (TAS) localization of GALM (the "GALM converts beta-D-GAL to alpha-D-GAL" reaction) to the cytosol.
Reason: Consistent with the cytoplasmic Leloir pathway; the most specific and appropriate location term for GALM. Core localization.
GO:0005829 cytosol
TAS
Reactome:R-HSA-9931926
ACCEPT
Summary: Reactome-curated (TAS) cytosol localization (defective-GALM reaction context). Duplicate of the preceding cytosol annotation from a related Reactome reaction.
Reason: Correct core localization; duplicate assertion of cytosol is acceptable.
GO:0004034 aldose 1-epimerase activity
IDA
PMID:30451973
Biallelic GALM pathogenic variants cause a novel type of gal...
ACCEPT
Summary: Direct assay (IDA) of aldose 1-epimerase activity in the study that identified GALM deficiency as a novel galactosemia; patient/variant proteins showed altered activity.
Reason: Core molecular function, independently confirmed in the disease-gene study.
GO:0004034 aldose 1-epimerase activity
IMP
PMID:30451973
Biallelic GALM pathogenic variants cause a novel type of gal...
ACCEPT
Summary: Mutant-phenotype (IMP) evidence that pathogenic GALM variants reduce aldose 1-epimerase activity, linking loss of this MF to disease.
Reason: Loss-of-function variants causing galactosemia type IV support the physiological relevance of this core molecular function.
GO:0033499 beta-D-galactose catabolic process via UDP-galactose, Leloir pathway
IMP
PMID:30451973
Biallelic GALM pathogenic variants cause a novel type of gal...
ACCEPT
Summary: Mutant-phenotype (IMP) evidence that GALM loss disrupts the Leloir pathway of galactose catabolism, causing galactose accumulation / galactosemia type IV.
Reason: Biallelic GALM variants cause a novel type of galactosemia by impairing the Leloir pathway; core biological process supported by human disease genetics.
GO:0033499 beta-D-galactose catabolic process via UDP-galactose, Leloir pathway
IDA
PMID:30451973
Biallelic GALM pathogenic variants cause a novel type of gal...
ACCEPT
Summary: Direct-assay (IDA) evidence supporting GALM's participation in the Leloir galactose catabolic pathway.
Reason: Core biological process, directly supported. Duplicate of the IBA/TAS Leloir-pathway annotations with independent experimental backing.
GO:0004034 aldose 1-epimerase activity
IDA
PMID:12753898
Identification and characterisation of human aldose 1-epimer...
ACCEPT
Summary: Direct assay (IDA) of aldose 1-epimerase activity on purified recombinant human GALM.
Reason: Core molecular function; the foundational biochemical characterization of the enzyme.
Supporting Evidence:
PMID:12753898
Enzyme assays show that the protein has aldose 1-epimerase activity and exhibits a preference for galactose over glucose.
GO:0005975 carbohydrate metabolic process
IDA
PMID:12753898
Identification and characterisation of human aldose 1-epimer...
KEEP AS NON CORE
Summary: Direct-assay evidence placing GALM in carbohydrate metabolism (mutarotation of hexose sugars), a high-level grouping process.
Reason: Correct but very general; the specific galactose/glucose metabolic process terms are more informative. Retained as a non-core parent. GALM is described as "a key enzyme of carbohydrate metabolism" (PMID:12753898).
Supporting Evidence:
PMID:12753898
Aldose 1-epimerase or mutarotase (EC 5.1.3.3) is a key enzyme of carbohydrate metabolism catalysing the interconversion of the alpha- and beta-anomers of hexose sugars such as glucose and galactose.
GO:0042803 protein homodimerization activity
IDA NOT
PMID:12753898
Identification and characterisation of human aldose 1-epimer...
ACCEPT
Summary: Negated (NOT) annotation: GALM does not have protein homodimerization activity. Biochemical and structural characterization established that GALM is a monomer.
Reason: The NOT annotation correctly records that GALM does not homodimerize. UniProt reports the SUBUNIT as Monomer (from PMID:12753898 and PMID:15026423). Retaining the negation is informative and consistent with the monomeric solution and crystal state.
GO:0070062 extracellular exosome
HDA
PMID:19056867
Large-scale proteomics and phosphoproteomics of urinary exos...
KEEP AS NON CORE
Summary: High-throughput mass-spectrometry (HDA) detection of GALM among proteins recovered from human urinary exosomes.
Reason: Reflects broad proteomic detection in secreted exosomes rather than the enzyme's site of catalytic function, which is the cytosol. Kept as a non-core localization; not part of the core Leloir-pathway function.
Supporting Evidence:
PMID:19056867
we used LC-MS/MS to profile the proteome of human urinary exosomes. Overall, the analysis identified 1132 proteins unambiguously
GO:0006006 glucose metabolic process
IDA
PMID:12753898
Identification and characterisation of human aldose 1-epimer...
KEEP AS NON CORE
Summary: Direct-assay evidence that GALM mutarotates D-glucose, participating in glucose metabolism.
Reason: GALM does interconvert glucose anomers, but with lower efficiency than galactose and a demonstrated preference for galactose (PMID:12753898). A real but secondary activity, not the core physiological role.
Supporting Evidence:
PMID:12753898
catalysing the interconversion of the alpha- and beta-anomers of hexose sugars such as glucose and galactose
GO:0006012 galactose metabolic process
IDA
PMID:12753898
Identification and characterisation of human aldose 1-epimer...
ACCEPT
Summary: Direct-assay evidence that GALM participates in galactose metabolism via mutarotation of galactose anomers.
Reason: Core biological process; directly demonstrated and consistent with the enzyme's preference for galactose. Foundational to the Leloir pathway.
Supporting Evidence:
PMID:12753898
catalysing the interconversion of the alpha- and beta-anomers of hexose sugars such as glucose and galactose

Core Functions

Aldose 1-epimerase (galactose mutarotase) activity: GALM interconverts the beta- and alpha-anomers of D-galactose in the cytosol, catalyzing the first step of the Leloir pathway and supplying the alpha-D-galactose required by galactokinase (GALK1).

Supporting Evidence:
  • PMID:12753898
    Aldose 1-epimerase or mutarotase (EC 5.1.3.3) is a key enzyme of carbohydrate metabolism catalysing the interconversion of the alpha- and beta-anomers of hexose sugars such as glucose and galactose.
  • PMID:30451973
    Biallelic GALM pathogenic variants cause a novel type of galactosemia.

References

Loading supporting content…

Download this section (compressed HTML)

πŸ“š Additional Documentation

Notes

(GALM-notes.md)

Loading supporting content…

Download this section (compressed HTML)

πŸ“„ View Raw YAML

Loading supporting content…

Download this section (compressed HTML)